Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart compared to NovoRapid in Adults with Type 1 Diabetes
Phase of Trial: Phase III
Latest Information Update: 26 Jul 2018
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms onset 5
- Sponsors Novo Nordisk
- 26 Jul 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 26 Jan 2017 Status changed from recruiting to active, no longer recruiting.